LRRK2 and Parkinson disease: Our data show that LRRK2 KO cells have increased mitochondrial maximum respiration, while LRRK2 mutations exhibit decreased maximum respiration, suggesting that alteration in LRRK2 activity in PD cells leads to impaired mitochondrial activity, however, the exact cellular effect might differ per cell strain and experimental conditions.